Search Reports
Categories
Categories

Global Isoniazid Tablets Market

Global Isoniazid Tablets Market Research Report 2025(Status and Outlook)

Report Code : EPR0735
Published Date : 17 July, 1905 | No of Pages: 190

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Isoniazid Tablets are a pharmaceutical product designed for the treatment of tuberculosis (TB), a bacterial infection that primarily affects the lungs. These tablets contain the active ingredient isoniazid, which is a first-line anti-tuberculosis drug. It works by inhibiting the synthesis of mycolic acids, an essential component of the bacterial cell wall, thereby preventing the growth and reproduction of Mycobacterium tuberculosis, the causative agent of TB. Isoniazid Tablets are typically prescribed as part of a combination therapy, which may include other anti-tuberculosis drugs such as rifampicin, pyrazinamide, and ethambutol. The tablets are oral dosage forms, allowing for easy administration and absorption in the gastrointestinal tract. They are an essential component in the management of both active TB and latent TB infection, playing a crucial role in the global effort to control and eradicate this infectious disease.

This report provides a deep insight into the global Isoniazid Tablets market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Isoniazid Tablets Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Isoniazid Tablets market in any manner.
Global Isoniazid Tablets Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sinopharm Guorui Pharmaceutical Co.
Ltd.
Harbin Pharmaceutical Group Pharmaceutical Factory
Tonghua Baishan Pharmaceutical Co.
Ltd.
Hunan Shentaichun Pharmaceutical Co.
Ltd.
Hubei Renyue Pharmaceutical Co.
Ltd.
Tiansheng Pharmaceutical Group Co.
Ltd.
Sancai Shiqi Pharmaceutical Co.
Ltd.
Hunan Kangerjia Pharmaceutical Co.
Ltd.
Sichuan Deyuan Pharmaceutical Group Co.
Ltd.
Hebei Changtian Pharmaceutical Co.
Ltd.
Jichuang Pharmaceutical Group Co.
Ltd.
Yunpeng Pharmaceutical Group Co.
Ltd.
Hebei Tiancheng Pharmaceutical Co.
Ltd.
Hubei Hendi Pharmaceutical Co.
Ltd.
Guangdong Xinfeng Pharmaceutical Co.
Ltd.
Hunan Xinhui Pharmaceutical Co.

Market Segmentation (by Type)
50mg
100mg

Market Segmentation (by Application)
Hospital
Clinic
Other

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Isoniazid Tablets Market
Overview of the regional outlook of the Isoniazid Tablets Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Isoniazid Tablets Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Isoniazid Tablets, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Isoniazid Tablets
      1.2 Key Market Segments
            1.2.1 Isoniazid Tablets Segment by Type
            1.2.2 Isoniazid Tablets Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Isoniazid Tablets Market Overview
      2.1 Global Market Overview
            2.1.1 Global Isoniazid Tablets Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Isoniazid Tablets Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Isoniazid Tablets Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Isoniazid Tablets Product Life Cycle
      3.3 Global Isoniazid Tablets Sales by Manufacturers (2020-2025)
      3.4 Global Isoniazid Tablets Revenue Market Share by Manufacturers (2020-2025)
      3.5 Isoniazid Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Isoniazid Tablets Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Isoniazid Tablets Market Competitive Situation and Trends
            3.8.1 Isoniazid Tablets Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Isoniazid Tablets Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Isoniazid Tablets Industry Chain Analysis
      4.1 Isoniazid Tablets Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Isoniazid Tablets Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Isoniazid Tablets Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Isoniazid Tablets Market
      5.7 ESG Ratings of Leading Companies
  6 Isoniazid Tablets Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Isoniazid Tablets Sales Market Share by Type (2020-2025)
      6.3 Global Isoniazid Tablets Market Size Market Share by Type (2020-2025)
      6.4 Global Isoniazid Tablets Price by Type (2020-2025)
  7 Isoniazid Tablets Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Isoniazid Tablets Market Sales by Application (2020-2025)
      7.3 Global Isoniazid Tablets Market Size (M USD) by Application (2020-2025)
      7.4 Global Isoniazid Tablets Sales Growth Rate by Application (2020-2025)
  8 Isoniazid Tablets Market Sales by Region
      8.1 Global Isoniazid Tablets Sales by Region
            8.1.1 Global Isoniazid Tablets Sales by Region
            8.1.2 Global Isoniazid Tablets Sales Market Share by Region
      8.2 Global Isoniazid Tablets Market Size by Region
            8.2.1 Global Isoniazid Tablets Market Size by Region
            8.2.2 Global Isoniazid Tablets Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Isoniazid Tablets Sales by Country
            8.3.2 North America Isoniazid Tablets Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Isoniazid Tablets Sales by Country
            8.4.2 Europe Isoniazid Tablets Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Isoniazid Tablets Sales by Region
            8.5.2 Asia Pacific Isoniazid Tablets Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Isoniazid Tablets Sales by Country
            8.6.2 South America Isoniazid Tablets Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Isoniazid Tablets Sales by Region
            8.7.2 Middle East and Africa Isoniazid Tablets Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Isoniazid Tablets Market Production by Region
      9.1 Global Production of Isoniazid Tablets by Region(2020-2025)
      9.2 Global Isoniazid Tablets Revenue Market Share by Region (2020-2025)
      9.3 Global Isoniazid Tablets Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Isoniazid Tablets Production
            9.4.1 North America Isoniazid Tablets Production Growth Rate (2020-2025)
            9.4.2 North America Isoniazid Tablets Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Isoniazid Tablets Production
            9.5.1 Europe Isoniazid Tablets Production Growth Rate (2020-2025)
            9.5.2 Europe Isoniazid Tablets Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Isoniazid Tablets Production (2020-2025)
            9.6.1 Japan Isoniazid Tablets Production Growth Rate (2020-2025)
            9.6.2 Japan Isoniazid Tablets Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Isoniazid Tablets Production (2020-2025)
            9.7.1 China Isoniazid Tablets Production Growth Rate (2020-2025)
            9.7.2 China Isoniazid Tablets Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Sinopharm Guorui Pharmaceutical Co.
            10.1.1 Sinopharm Guorui Pharmaceutical Co. Basic Information
            10.1.2 Sinopharm Guorui Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.1.3 Sinopharm Guorui Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.1.4 Sinopharm Guorui Pharmaceutical Co. Business Overview
            10.1.5 Sinopharm Guorui Pharmaceutical Co. SWOT Analysis
            10.1.6 Sinopharm Guorui Pharmaceutical Co. Recent Developments
      10.2 Ltd.
            10.2.1 Ltd. Basic Information
            10.2.2 Ltd. Isoniazid Tablets Product Overview
            10.2.3 Ltd. Isoniazid Tablets Product Market Performance
            10.2.4 Ltd. Business Overview
            10.2.5 Ltd. SWOT Analysis
            10.2.6 Ltd. Recent Developments
      10.3 Harbin Pharmaceutical Group Pharmaceutical Factory
            10.3.1 Harbin Pharmaceutical Group Pharmaceutical Factory Basic Information
            10.3.2 Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Product Overview
            10.3.3 Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Product Market Performance
            10.3.4 Harbin Pharmaceutical Group Pharmaceutical Factory Business Overview
            10.3.5 Harbin Pharmaceutical Group Pharmaceutical Factory SWOT Analysis
            10.3.6 Harbin Pharmaceutical Group Pharmaceutical Factory Recent Developments
      10.4 Tonghua Baishan Pharmaceutical Co.
            10.4.1 Tonghua Baishan Pharmaceutical Co. Basic Information
            10.4.2 Tonghua Baishan Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.4.3 Tonghua Baishan Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.4.4 Tonghua Baishan Pharmaceutical Co. Business Overview
            10.4.5 Tonghua Baishan Pharmaceutical Co. Recent Developments
      10.5 Ltd.
            10.5.1 Ltd. Basic Information
            10.5.2 Ltd. Isoniazid Tablets Product Overview
            10.5.3 Ltd. Isoniazid Tablets Product Market Performance
            10.5.4 Ltd. Business Overview
            10.5.5 Ltd. Recent Developments
      10.6 Hunan Shentaichun Pharmaceutical Co.
            10.6.1 Hunan Shentaichun Pharmaceutical Co. Basic Information
            10.6.2 Hunan Shentaichun Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.6.3 Hunan Shentaichun Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.6.4 Hunan Shentaichun Pharmaceutical Co. Business Overview
            10.6.5 Hunan Shentaichun Pharmaceutical Co. Recent Developments
      10.7 Ltd.
            10.7.1 Ltd. Basic Information
            10.7.2 Ltd. Isoniazid Tablets Product Overview
            10.7.3 Ltd. Isoniazid Tablets Product Market Performance
            10.7.4 Ltd. Business Overview
            10.7.5 Ltd. Recent Developments
      10.8 Hubei Renyue Pharmaceutical Co.
            10.8.1 Hubei Renyue Pharmaceutical Co. Basic Information
            10.8.2 Hubei Renyue Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.8.3 Hubei Renyue Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.8.4 Hubei Renyue Pharmaceutical Co. Business Overview
            10.8.5 Hubei Renyue Pharmaceutical Co. Recent Developments
      10.9 Ltd.
            10.9.1 Ltd. Basic Information
            10.9.2 Ltd. Isoniazid Tablets Product Overview
            10.9.3 Ltd. Isoniazid Tablets Product Market Performance
            10.9.4 Ltd. Business Overview
            10.9.5 Ltd. Recent Developments
      10.10 Tiansheng Pharmaceutical Group Co.
            10.10.1 Tiansheng Pharmaceutical Group Co. Basic Information
            10.10.2 Tiansheng Pharmaceutical Group Co. Isoniazid Tablets Product Overview
            10.10.3 Tiansheng Pharmaceutical Group Co. Isoniazid Tablets Product Market Performance
            10.10.4 Tiansheng Pharmaceutical Group Co. Business Overview
            10.10.5 Tiansheng Pharmaceutical Group Co. Recent Developments
      10.11 Ltd.
            10.11.1 Ltd. Basic Information
            10.11.2 Ltd. Isoniazid Tablets Product Overview
            10.11.3 Ltd. Isoniazid Tablets Product Market Performance
            10.11.4 Ltd. Business Overview
            10.11.5 Ltd. Recent Developments
      10.12 Sancai Shiqi Pharmaceutical Co.
            10.12.1 Sancai Shiqi Pharmaceutical Co. Basic Information
            10.12.2 Sancai Shiqi Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.12.3 Sancai Shiqi Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.12.4 Sancai Shiqi Pharmaceutical Co. Business Overview
            10.12.5 Sancai Shiqi Pharmaceutical Co. Recent Developments
      10.13 Ltd.
            10.13.1 Ltd. Basic Information
            10.13.2 Ltd. Isoniazid Tablets Product Overview
            10.13.3 Ltd. Isoniazid Tablets Product Market Performance
            10.13.4 Ltd. Business Overview
            10.13.5 Ltd. Recent Developments
      10.14 Hunan Kangerjia Pharmaceutical Co.
            10.14.1 Hunan Kangerjia Pharmaceutical Co. Basic Information
            10.14.2 Hunan Kangerjia Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.14.3 Hunan Kangerjia Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.14.4 Hunan Kangerjia Pharmaceutical Co. Business Overview
            10.14.5 Hunan Kangerjia Pharmaceutical Co. Recent Developments
      10.15 Ltd.
            10.15.1 Ltd. Basic Information
            10.15.2 Ltd. Isoniazid Tablets Product Overview
            10.15.3 Ltd. Isoniazid Tablets Product Market Performance
            10.15.4 Ltd. Business Overview
            10.15.5 Ltd. Recent Developments
      10.16 Sichuan Deyuan Pharmaceutical Group Co.
            10.16.1 Sichuan Deyuan Pharmaceutical Group Co. Basic Information
            10.16.2 Sichuan Deyuan Pharmaceutical Group Co. Isoniazid Tablets Product Overview
            10.16.3 Sichuan Deyuan Pharmaceutical Group Co. Isoniazid Tablets Product Market Performance
            10.16.4 Sichuan Deyuan Pharmaceutical Group Co. Business Overview
            10.16.5 Sichuan Deyuan Pharmaceutical Group Co. Recent Developments
      10.17 Ltd.
            10.17.1 Ltd. Basic Information
            10.17.2 Ltd. Isoniazid Tablets Product Overview
            10.17.3 Ltd. Isoniazid Tablets Product Market Performance
            10.17.4 Ltd. Business Overview
            10.17.5 Ltd. Recent Developments
      10.18 Hebei Changtian Pharmaceutical Co.
            10.18.1 Hebei Changtian Pharmaceutical Co. Basic Information
            10.18.2 Hebei Changtian Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.18.3 Hebei Changtian Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.18.4 Hebei Changtian Pharmaceutical Co. Business Overview
            10.18.5 Hebei Changtian Pharmaceutical Co. Recent Developments
      10.19 Ltd.
            10.19.1 Ltd. Basic Information
            10.19.2 Ltd. Isoniazid Tablets Product Overview
            10.19.3 Ltd. Isoniazid Tablets Product Market Performance
            10.19.4 Ltd. Business Overview
            10.19.5 Ltd. Recent Developments
      10.20 Jichuang Pharmaceutical Group Co.
            10.20.1 Jichuang Pharmaceutical Group Co. Basic Information
            10.20.2 Jichuang Pharmaceutical Group Co. Isoniazid Tablets Product Overview
            10.20.3 Jichuang Pharmaceutical Group Co. Isoniazid Tablets Product Market Performance
            10.20.4 Jichuang Pharmaceutical Group Co. Business Overview
            10.20.5 Jichuang Pharmaceutical Group Co. Recent Developments
      10.21 Ltd.
            10.21.1 Ltd. Basic Information
            10.21.2 Ltd. Isoniazid Tablets Product Overview
            10.21.3 Ltd. Isoniazid Tablets Product Market Performance
            10.21.4 Ltd. Business Overview
            10.21.5 Ltd. Recent Developments
      10.22 Yunpeng Pharmaceutical Group Co.
            10.22.1 Yunpeng Pharmaceutical Group Co. Basic Information
            10.22.2 Yunpeng Pharmaceutical Group Co. Isoniazid Tablets Product Overview
            10.22.3 Yunpeng Pharmaceutical Group Co. Isoniazid Tablets Product Market Performance
            10.22.4 Yunpeng Pharmaceutical Group Co. Business Overview
            10.22.5 Yunpeng Pharmaceutical Group Co. Recent Developments
      10.23 Ltd.
            10.23.1 Ltd. Basic Information
            10.23.2 Ltd. Isoniazid Tablets Product Overview
            10.23.3 Ltd. Isoniazid Tablets Product Market Performance
            10.23.4 Ltd. Business Overview
            10.23.5 Ltd. Recent Developments
      10.24 Hebei Tiancheng Pharmaceutical Co.
            10.24.1 Hebei Tiancheng Pharmaceutical Co. Basic Information
            10.24.2 Hebei Tiancheng Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.24.3 Hebei Tiancheng Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.24.4 Hebei Tiancheng Pharmaceutical Co. Business Overview
            10.24.5 Hebei Tiancheng Pharmaceutical Co. Recent Developments
      10.25 Ltd.
            10.25.1 Ltd. Basic Information
            10.25.2 Ltd. Isoniazid Tablets Product Overview
            10.25.3 Ltd. Isoniazid Tablets Product Market Performance
            10.25.4 Ltd. Business Overview
            10.25.5 Ltd. Recent Developments
      10.26 Hubei Hendi Pharmaceutical Co.
            10.26.1 Hubei Hendi Pharmaceutical Co. Basic Information
            10.26.2 Hubei Hendi Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.26.3 Hubei Hendi Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.26.4 Hubei Hendi Pharmaceutical Co. Business Overview
            10.26.5 Hubei Hendi Pharmaceutical Co. Recent Developments
      10.27 Ltd.
            10.27.1 Ltd. Basic Information
            10.27.2 Ltd. Isoniazid Tablets Product Overview
            10.27.3 Ltd. Isoniazid Tablets Product Market Performance
            10.27.4 Ltd. Business Overview
            10.27.5 Ltd. Recent Developments
      10.28 Guangdong Xinfeng Pharmaceutical Co.
            10.28.1 Guangdong Xinfeng Pharmaceutical Co. Basic Information
            10.28.2 Guangdong Xinfeng Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.28.3 Guangdong Xinfeng Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.28.4 Guangdong Xinfeng Pharmaceutical Co. Business Overview
            10.28.5 Guangdong Xinfeng Pharmaceutical Co. Recent Developments
      10.29 Ltd.
            10.29.1 Ltd. Basic Information
            10.29.2 Ltd. Isoniazid Tablets Product Overview
            10.29.3 Ltd. Isoniazid Tablets Product Market Performance
            10.29.4 Ltd. Business Overview
            10.29.5 Ltd. Recent Developments
      10.30 Hunan Xinhui Pharmaceutical Co.
            10.30.1 Hunan Xinhui Pharmaceutical Co. Basic Information
            10.30.2 Hunan Xinhui Pharmaceutical Co. Isoniazid Tablets Product Overview
            10.30.3 Hunan Xinhui Pharmaceutical Co. Isoniazid Tablets Product Market Performance
            10.30.4 Hunan Xinhui Pharmaceutical Co. Business Overview
            10.30.5 Hunan Xinhui Pharmaceutical Co. Recent Developments
  11 Isoniazid Tablets Market Forecast by Region
      11.1 Global Isoniazid Tablets Market Size Forecast
      11.2 Global Isoniazid Tablets Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Isoniazid Tablets Market Size Forecast by Country
            11.2.3 Asia Pacific Isoniazid Tablets Market Size Forecast by Region
            11.2.4 South America Isoniazid Tablets Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Isoniazid Tablets by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Isoniazid Tablets Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Isoniazid Tablets by Type (2026-2033)
            12.1.2 Global Isoniazid Tablets Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Isoniazid Tablets by Type (2026-2033)
      12.2 Global Isoniazid Tablets Market Forecast by Application (2026-2033)
            12.2.1 Global Isoniazid Tablets Sales (K Units) Forecast by Application
            12.2.2 Global Isoniazid Tablets Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Sinopharm Guorui Pharmaceutical Co.
Ltd.
Harbin Pharmaceutical Group Pharmaceutical Factory
Tonghua Baishan Pharmaceutical Co.
Ltd.
Hunan Shentaichun Pharmaceutical Co.
Ltd.
Hubei Renyue Pharmaceutical Co.
Ltd.
Tiansheng Pharmaceutical Group Co.
Ltd.
Sancai Shiqi Pharmaceutical Co.
Ltd.
Hunan Kangerjia Pharmaceutical Co.
Ltd.
Sichuan Deyuan Pharmaceutical Group Co.
Ltd.
Hebei Changtian Pharmaceutical Co.
Ltd.
Jichuang Pharmaceutical Group Co.
Ltd.
Yunpeng Pharmaceutical Group Co.
Ltd.
Hebei Tiancheng Pharmaceutical Co.
Ltd.
Hubei Hendi Pharmaceutical Co.
Ltd.
Guangdong Xinfeng Pharmaceutical Co.
Ltd.
Hunan Xinhui Pharmaceutical Co.
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400